BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 22357632)

  • 1. Redundant and antagonistic functions of galectin-1, -3, and -8 in the elicitation of T cell responses.
    Tribulatti MV; Figini MG; Carabelli J; Cattaneo V; Campetella O
    J Immunol; 2012 Apr; 188(7):2991-9. PubMed ID: 22357632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Galectin-8 provides costimulatory and proliferative signals to T lymphocytes.
    Tribulatti MV; Cattaneo V; Hellman U; Mucci J; Campetella O
    J Leukoc Biol; 2009 Aug; 86(2):371-80. PubMed ID: 19401394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Galectin-8 tandem-repeat structure is essential for T-cell proliferation but not for co-stimulation.
    Cattaneo V; Tribulatti MV; Campetella O
    Biochem J; 2011 Feb; 434(1):153-60. PubMed ID: 21091438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Galectin-1 tunes TCR binding and signal transduction to regulate CD8 burst size.
    Liu SD; Tomassian T; Bruhn KW; Miller JF; Poirier F; Miceli MC
    J Immunol; 2009 May; 182(9):5283-95. PubMed ID: 19380775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Costimulatory requirements of naive CD4+ T cells. ICAM-1 or B7-1 can costimulate naive CD4 T cell activation but both are required for optimum response.
    Dubey C; Croft M; Swain SL
    J Immunol; 1995 Jul; 155(1):45-57. PubMed ID: 7541426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of a double-CRD-mutated Gal-8 recombinant protein that retains co-stimulatory activity on antigen-specific T-cell response.
    Schroeder MN; Tribulatti MV; Carabelli J; André-Leroux G; Caramelo JJ; Cattaneo V; Campetella O
    Biochem J; 2016 Apr; 473(7):887-98. PubMed ID: 26795039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigen-specific B cells preferentially induce CD4+ T cells to produce IL-4.
    Macaulay AE; DeKruyff RH; Goodnow CC; Umetsu DT
    J Immunol; 1997 May; 158(9):4171-9. PubMed ID: 9126977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Galectin-1 specifically modulates TCR signals to enhance TCR apoptosis but inhibit IL-2 production and proliferation.
    Vespa GN; Lewis LA; Kozak KR; Moran M; Nguyen JT; Baum LG; Miceli MC
    J Immunol; 1999 Jan; 162(2):799-806. PubMed ID: 9916701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ex vivo activated OVA specific and non-specific CD4+CD25+ regulatory T cells exhibit comparable suppression to OVA mediated T cell responses.
    Li J; Bracht M; Shang X; Radewonuk J; Emmell E; Griswold DE; Li L
    Cell Immunol; 2006 Jun; 241(2):75-84. PubMed ID: 17010326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two roles for Ia in antigen-specific T cell activation. II. Toward a Velcro model of antigen recognition.
    Kim KH; Thomas DW
    J Immunol; 1988 Apr; 140(8):2500-7. PubMed ID: 3258611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intradermal injections of polyarginine-containing immunogenic antigens preferentially elicit Tc1 and Th1 activation and antitumour immunity.
    Mitsui H; Okamoto T; Kanzaki M; Inozume T; Shibagaki N; Shimada S
    Br J Dermatol; 2010 Jan; 162(1):29-41. PubMed ID: 19863514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD29 and CD7 mediate galectin-3-induced type II T-cell apoptosis.
    Fukumori T; Takenaka Y; Yoshii T; Kim HR; Hogan V; Inohara H; Kagawa S; Raz A
    Cancer Res; 2003 Dec; 63(23):8302-11. PubMed ID: 14678989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Galectin-8 activates dendritic cells and stimulates antigen-specific immune response elicitation.
    Carabelli J; Quattrocchi V; D'Antuono A; Zamorano P; Tribulatti MV; Campetella O
    J Leukoc Biol; 2017 Nov; 102(5):1237-1247. PubMed ID: 28811319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural killer cell depletion fails to influence initial CD4 T cell commitment in vivo in exogenous antigen-stimulated cytokine and antibody responses.
    Wang M; Ellison CA; Gartner JG; HayGlass KT
    J Immunol; 1998 Feb; 160(3):1098-105. PubMed ID: 9570522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of in vivo regulatory properties of T cells activated in vitro by TGFbeta2-treated antigen presenting cells.
    Kezuka T; Streilein JW
    Invest Ophthalmol Vis Sci; 2000 May; 41(6):1410-21. PubMed ID: 10798657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of retinal pigmented epithelial cells and CD4 T cells leads to T-cell anergy.
    Gregerson DS; Heuss ND; Lew KL; McPherson SW; Ferrington DA
    Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4654-63. PubMed ID: 17898289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo activation of naive T cells by antigen-presenting B cells.
    Morris SC; Lees A; Finkelman FD
    J Immunol; 1994 Apr; 152(8):3777-85. PubMed ID: 8144947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraperitoneal Echinococcus multilocularis infection in C57BL/6 mice affects CD40 and B7 costimulator expression on peritoneal macrophages and impairs peritoneal T cell activation.
    Mejri N; Gottstein B
    Parasite Immunol; 2006 Aug; 28(8):373-85. PubMed ID: 16879309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B lymphocytes as antigen-presenting cells for CD4+ T cell priming in vivo.
    Constant SL
    J Immunol; 1999 May; 162(10):5695-703. PubMed ID: 10229801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NKT cell-dependent regulation of secondary antigen-specific, conventional CD4+ T cell immune responses.
    Shin Y; Hong C; Lee H; Shin JH; Hong S; Park SH
    J Immunol; 2010 May; 184(10):5589-94. PubMed ID: 20375305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.